Edition:
India

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

0.64USD
10:09pm IST
Change (% chg)

$-0.01 (-1.05%)
Prev Close
$0.64
Open
$0.65
Day's High
$0.65
Day's Low
$0.63
Volume
17,074
Avg. Vol
135,297
52-wk High
$3.39
52-wk Low
$0.61

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: 1.26
Market Cap(Mil.): $48.17
Shares Outstanding(Mil.): 74.69
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates